Incannex Healthcare (IXHL) News Today → Must-See: Elon’s New Invention is Absolutely Insane (From InvestorPlace) (Ad) Free IXHL Stock Alerts $2.50 -0.28 (-10.07%) (As of 05/17/2024 08:53 PM ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 15, 2024 | marketbeat.comIncannex Healthcare Inc. (NASDAQ:IXHL) Short Interest Up 31.3% in AprilIncannex Healthcare Inc. (NASDAQ:IXHL - Get Free Report) saw a significant increase in short interest during the month of April. As of April 30th, there was short interest totalling 54,900 shares, an increase of 31.3% from the April 15th total of 41,800 shares. Based on an average daily volume of 306,200 shares, the short-interest ratio is presently 0.2 days. Currently, 0.5% of the company's shares are sold short.May 7, 2024 | finanznachrichten.deIncannex Healthcare: Incannex Complete Successful Pre-IND Meeting with the FDA for CannQuit-O for treatment of opioid use disorderMay 7, 2024 | globenewswire.comIncannex Complete Successful Pre-IND Meeting with the FDA for CannQuit-O for treatment of opioid use disorderMarch 29, 2024 | msn.comPsyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's InfluenceMarch 28, 2024 | marketbeat.comShort Interest in Incannex Healthcare Inc. (NASDAQ:IXHL) Grows By 113.1%Incannex Healthcare Inc. (NASDAQ:IXHL - Get Free Report) was the target of a significant growth in short interest in the month of March. As of March 15th, there was short interest totalling 208,200 shares, a growth of 113.1% from the February 29th total of 97,700 shares. Based on an average daily trading volume, of 309,800 shares, the short-interest ratio is presently 0.7 days. Approximately 1.8% of the company's shares are short sold.March 24, 2024 | morningstar.comIncannex Healthcare Inc IXHLMarch 22, 2024 | msn.comPsychedelic-Assisted Therapy Advancements Create A New Horizon For Mental Health In ColoradoMarch 19, 2024 | marketbeat.comTrading was temporarily halted for "IXHL" at 03:03 PM with a stated reason of "LULD pause." Trading set to resume at 04:03 PM. March 3, 2024 | marketbeat.comIncannex Healthcare Inc. (NASDAQ:IXHL) Short Interest Up 57.3% in FebruaryIncannex Healthcare Inc. (NASDAQ:IXHL - Get Free Report) was the recipient of a large increase in short interest in the month of February. As of February 15th, there was short interest totalling 97,200 shares, an increase of 57.3% from the January 31st total of 61,800 shares. Based on an average trading volume of 94,300 shares, the short-interest ratio is presently 1.0 days. Approximately 0.6% of the company's shares are sold short.February 28, 2024 | markets.businessinsider.comIncannex's Phase 2 Psi-GAD1 Trial Of Psilocybin Meets Primary Endpoint; Stock Surges 39%February 28, 2024 | msn.comNovavax, Applied Therapeutics, Incannex among healthcare moversFebruary 28, 2024 | finance.yahoo.comIncannex Announces Positive Topline Results from Phase 2 Psi-GAD1 Clinical Trial of Psilocybin in Generalised Anxiety DisorderFebruary 28, 2024 | marketbeat.comTrading was temporarily halted for "IXHL" at 09:02 AM with a stated reason of "LULD pause."February 28, 2024 | marketbeat.comTrading was temporarily halted for "IXHL" at 09:02 AM with a stated reason of "LULD pause." Trading set to resume at 09:02 AM. February 21, 2024 | marketbeat.comTrading was temporarily halted for "IXHL" at 12:02 PM with a stated reason of "LULD pause."February 21, 2024 | marketbeat.comTrading was temporarily halted for "IXHL" at 12:02 PM with a stated reason of "LULD pause." Trading set to resume at 12:02 PM. February 16, 2024 | finanznachrichten.deIncannex Healthcare: Incannex Completes Successful Pre-IND Meeting with the FDA for CannQuit-N; a Novel Solution for Tobacco Smoking CessationFebruary 16, 2024 | finance.yahoo.comIncannex Completes Successful Pre-IND Meeting with the FDA for CannQuit-N; a Novel Solution for Tobacco Smoking CessationFebruary 16, 2024 | globenewswire.comIncannex Completes Successful Pre-IND Meeting with the FDA for CannQuit-N; a Novel Solution for Tobacco Smoking CessationFebruary 4, 2024 | finance.yahoo.comWe're Keeping An Eye On Incannex Healthcare's (NASDAQ:IXHL) Cash Burn RateFebruary 1, 2024 | proactiveinvestors.comIncannex Healthcare begins dosing in Phase 2 clinical trial...February 1, 2024 | finance.yahoo.comClarion Clinics Open for Psychedelic-Assisted TreatmentsJanuary 25, 2024 | msn.comPodcast: International Cannabis And Psychedelics Co. Is Working 'Hand In Hand' With FDA To Forge New Therapy FrontiersJanuary 24, 2024 | finance.yahoo.comIncannex Commences Dosing in Phase 2 Clinical Trial Assessing IHL-675A in Patients with Rheumatoid ArthritisJanuary 18, 2024 | finance.yahoo.comIncannex Completes Dosing and Therapy in Phase 2 “PsiGAD” Clinical Trial Assessing Psilocybin-assisted Psychotherapy for Generalized Anxiety Disorder; Data Analysis CommencesJanuary 17, 2024 | finance.yahoo.comIncannex Receives IRB Approval for the RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep ApneaJanuary 14, 2024 | seekingalpha.comIXHL Incannex Healthcare Inc.January 12, 2024 | marketbeat.comShort Interest in Incannex Healthcare Inc. (NASDAQ:IXHL) Grows By 107.5%Incannex Healthcare Inc. (NASDAQ:IXHL - Get Free Report) was the recipient of a large growth in short interest in December. As of December 31st, there was short interest totalling 93,600 shares, a growth of 107.5% from the December 15th total of 45,100 shares. Based on an average daily volume of 65,000 shares, the short-interest ratio is currently 1.4 days. Currently, 0.0% of the shares of the stock are short sold.December 28, 2023 | marketbeat.comIncannex Healthcare Inc. (NASDAQ:IXHL) Sees Significant Increase in Short InterestIncannex Healthcare Inc. (NASDAQ:IXHL - Get Free Report) saw a significant increase in short interest in the month of December. As of December 15th, there was short interest totalling 45,100 shares, an increase of 705.4% from the November 30th total of 5,600 shares. Based on an average trading volume of 62,900 shares, the days-to-cover ratio is presently 0.7 days. Currently, 0.0% of the shares of the stock are short sold.December 27, 2023 | msn.comPsyched: Biden Approves Psychedelics Trials, RFK, Australia's First Legal Dedicated Clinic & MoreDecember 24, 2023 | benzinga.comIncannex Healthcare Stock (NASDAQ:IXHL) Dividends: History, Yield and DatesDecember 23, 2023 | msn.comIncannex Healthcare To Open First Psychedelic-Assisted Therapy Clinic In AustraliaDecember 20, 2023 | marketbeat.com5 Biotech stocks tapping into unmet mental health treatment needs (IXHL)Here are five biotech companies currently working on drug candidates that tap into this soaring need for life-saving mental health treatments.December 6, 2023 | marketbeat.comTrading was temporarily halted for "IXHL" at 10:12 AM with a stated reason of "LULD pause."December 6, 2023 | finance.yahoo.comIncannex Update on IHL-42X Drug Candidate in Phase 2/3 Clinical Trial in Obstructive Sleep ApneaDecember 5, 2023 | marketbeat.comTrading was temporarily halted for "IXHL" at 10:12 AM with a stated reason of "LULD pause."December 5, 2023 | marketbeat.comTrading was temporarily halted for "IXHL" at 10:12 AM with a stated reason of "LULD pause."December 5, 2023 | marketbeat.comTrading was temporarily halted for "IXHL" at 10:12 AM with a stated reason of "LULD pause."December 4, 2023 | marketbeat.comTrading was temporarily halted for "IXHL" at 12:12 PM with a stated reason of "LULD pause."December 4, 2023 | marketbeat.comTrading was temporarily halted for "IXHL" at 12:12 PM with a stated reason of "LULD pause."December 4, 2023 | marketbeat.comTrading was temporarily halted for "IXHL" at 12:12 PM with a stated reason of "LULD pause."December 4, 2023 | marketbeat.comTrading was temporarily halted for "IXHL" at 12:12 PM with a stated reason of "LULD pause."November 30, 2023 | msn.comU.S. stocks mixed at close of trade; Dow Jones Industrial Average up 1.47%November 30, 2023 | marketbeat.comTrading was temporarily halted for "IXHL" at 03:11 PM with a stated reason of "LULD pause." Trading set to resume at 04:11 PM. November 30, 2023 | marketbeat.comTrading was temporarily halted for "IXHL" at 02:11 PM with a stated reason of "LULD pause."November 30, 2023 | marketbeat.comTrading was temporarily halted for "IXHL" at 02:11 PM with a stated reason of "LULD pause."November 30, 2023 | marketbeat.comTrading was temporarily halted for "IXHL" at 02:11 PM with a stated reason of "LULD pause."November 30, 2023 | marketbeat.comTrading was temporarily halted for "IXHL" at 02:11 PM with a stated reason of "LULD pause."November 30, 2023 | marketbeat.comTrading was temporarily halted for "IXHL" at 02:11 PM with a stated reason of "LULD pause."November 30, 2023 | marketbeat.comTrading was temporarily halted for "IXHL" at 02:11 PM with a stated reason of "LULD pause." Trading set to resume at 02:11 PM. Get Incannex Healthcare News Delivered to You Automatically Sign up to receive the latest news and ratings for IXHL and its competitors with MarketBeat's FREE daily newsletter. Email Address Must-See: Elon’s New Invention is Absolutely Insane (Ad)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone. Click here for the full story… IXHL Media Mentions By Week IXHL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IXHL News Sentiment▼1.510.42▲Average Medical News Sentiment IXHL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IXHL Articles This Week▼22▲IXHL Articles Average Week Get Incannex Healthcare News Delivered to You Automatically Sign up to receive the latest news and ratings for IXHL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Atossa Therapeutics News Inventiva News Organigram News Acrivon Therapeutics News Zevra Therapeutics News Telomir Pharmaceuticals News Lifecore Biomedical News Trevi Therapeutics News Conduit Pharmaceuticals News Galectin Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IXHL) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaShocking: One AI startup's revenue could surge 4,735%Manward PressCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingElon’s New Device is About to Shock the WorldInvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersMost important medical advance in 100 yearsThe Oxford ClubDems have chosen Biden replacement?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Incannex Healthcare Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.